ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 624851 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 624851; 2) Community: the network communities that were significantly associated with the response to NSC 624851; 3) Molecule: the relationships between components within communities and NSC 624851; 4) MDR: the compounds that were significantly associated with the NSC 624851.

NSC Compound Enrichment Correlation
NSC 208652 2,4-Quinazolinediamine, 5-chloro-6-[[(3,4-dichlorophenyl)amino]methyl]- 0.00701295499506023 0.3641685
NSC 321239 Mercury, (2-hydroxy-5-nitrophenyl)(6-thioguanosinato-N(7),S(6))- 0.00701295499506023 0.36510051
NSC 373355 Saframycin R 0.00701295499506023 0.29734124
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.00701295499506023 0.29811275
NSC 44585 9H-Purin-2-amine, 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9-(2-methylpropyl)- (9CI) 0.00701295499506023 0.17424077
NSC 48300 ANTINEOPLASTIC-48300 0.00701295499506023 0.3723773
NSC 610456 Camptothecin Derivative 0.00701295499506023 0.49447754
NSC 628665 Null 0.00838963112864931 0.58151233
NSC 639976 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)- phenyl]ethylidene]-5-[(4-morpholinyl)methyl]-, hydrochloride 0.00838963112864931 0.46114688
NSC 640083 Null 0.00838963112864931 0.18986594
Total:106  Current:28    [First] [Prev] [Next] [Last]